Cargando…
The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)
Autores principales: | Pineton de Chambrun, Marc, Moyon, Quentin, Faguer, Stanislas, Urbanski, Geoffrey, Mathian, Alexis, Zucman, Noémie, Werner, Marie, Luyt, Charles-Edouard, Verlicchi, Franco, Amoura, Zahir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648572/ https://www.ncbi.nlm.nih.gov/pubmed/34890829 http://dx.doi.org/10.1016/j.jaip.2021.11.023 |
Ejemplares similares
-
Clarkson’s Disease Episode or Secondary Systemic Capillary Leak-Syndrome: That Is the Question!
por: Pineton de Chambrun, Marc, et al.
Publicado: (2021) -
SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease)
por: Pineton de Chambrun, Marc, et al.
Publicado: (2020) -
Management of Acute Episodes of Clarkson Disease (Monoclonal Gammopathy-Associated Systemic Capillary Leak Syndrome) With Intravenous Immunoglobulins
por: Pecker, Mark S., et al.
Publicado: (2022) -
Anticancer Drug-Induced Capillary Leak Syndrome
por: Izzedine, Hassan, et al.
Publicado: (2022) -
Inflammatory Markers of the Systemic Capillary Leak Syndrome (Clarkson Disease)
por: Xie, Zhihui, et al.
Publicado: (2014)